News

Novo Integrated Sciences Provides Update on Certain Current Events

BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today provides an update with respect to…

1 year ago

GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance

AI-powered technology will expand access to scans by enabling a broader set of healthcare providers to perform cardiac exams with…

1 year ago

LivaNova Board Appoints J. Christopher Barry as New Director

Long-time Director Andrea Saia to retire from the BoardLONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its…

1 year ago

Black Book Announces Top Client-Rated Coding, Transcription, Clinical Documentation Improvement and HIM Vendors at AHIMA 2023

Four thousand healthcare solution users rated user experience among the top-performing category vendors in the 22 HIM-focused customer satisfaction surveys.BALTIMORE,…

1 year ago

Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™

DuraGraft is the first and only FDA cleared medical device for use as an intra-operative vascular conduit storage and flushing…

1 year ago

Bon Natural Life Limited Announces Signing MOU for Distributing Jiangwang Spirits in China

XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of…

1 year ago

Bon Natural Life Limited Announces Signing MOU for Distributing Jiangwang Spirits in China

XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of…

1 year ago

Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting

BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical…

1 year ago

Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit

VANCOUVER, British Columbia, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that…

1 year ago

Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit

IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on…

1 year ago